All studies
RecruitingNAINTERVENTIONAL

Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma

The PRONTO clinical trial is studying an advanced form of radiation called proton beam therapy (PBT) for people who have had surgery for cancer of the parotid gland (the main salivary gland in front of the ear). Standard radiotherapy is very effective at keeping cancer away, but it can harm nearby healthy tissues, often leading to permanent loss of taste and severe dry mouth. Proton beam therapy is different because the beams can be stopped exactly where the cancer was, delivering less radiation to the mouth and tongue. In this NHS study, all eligible patients receive proton therapy at one of the two UK centres in Manchester or London. Researchers want to find out whether this gentler approach protects patients' sense of taste, prevents dry mouth, and improves their overall quality of life during and after recovery.

At a glance

Status
Recruiting
Phase
NA
Sponsor
The Christie NHS Foundation Trust
Enrolment target
97
Start
05 Sep 2025
Estimated completion
01 Sep 2029

What is this study about?

The parotid glands are salivary glands located just in front of your ears. While cancers starting here are relatively rare, standard treatment usually involves an operation to remove the tumour, followed by radiotherapy to destroy any microscopic cancer cells left behind. Traditional radiotherapy uses photon X-rays. While this is very good at curing or controlling the cancer, the radiation beams pass through healthy tissues, which often damages the taste buds and saliva glands. Many patients are left with long-term taste changes and a dry mouth.

Proton beam therapy (PBT) is a newer, highly targeted type of radiotherapy. Instead of X-rays passing all the way through your head, proton beams deposit their energy directly into the treatment area and stop. This means nearby healthy organs—such as the tongue, mouth, and brainstem—receive much lower doses of radiation. Doctors believe this could significantly reduce short-term and permanent side effects, making it easier for patients to eat, enjoy food, and maintain their weight.

PRONTO is part of an NHS England research programme evaluating proton therapy across the UK. Because this is not a randomised trial, every patient who joins will receive proton beam therapy rather than standard radiotherapy. The information gathered through questionnaires and medical checks will be compared with typical results from standard treatment to help the NHS decide how best to use proton therapy in the future.

Key takeaways

  • PRONTO tests whether proton beam therapy reduces taste loss and dry mouth after parotid cancer surgery.
  • Proton beams stop precisely at the treatment area, sparing more healthy mouth tissue than standard X-rays.
  • All eligible patients in the trial will receive proton therapy; there is no random choice of treatment.
  • Treatment is delivered at NHS specialist centres in Manchester or London, with accommodation provided for those travelling.
  • Participation is completely voluntary and will not affect your standard NHS rights.

Who may be eligible?

This study is open to adults aged 18 and over who have recently had surgery to remove a primary cancerous tumour from their parotid gland. To take part, your medical team must have decided that you need radiotherapy to the area where the tumour was removed to lower the chance of the cancer returning.

You will not be able to take part if you have previously received radiotherapy to your head or neck, or if you need chemotherapy as part of your treatment. The study is also not suitable for people whose cancer has spread from another part of the body (such as skin cancer that spread to the parotid gland), or for tumours that could not be mostly removed by surgery.

Because treatment takes place at specialist NHS centres in either London or Manchester, you must be able and willing to travel for your care and attend regular follow-up visits.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or over.
  2. I have been diagnosed with cancer in my parotid salivary gland.
  3. I have had surgery to remove the tumour.
  4. My cancer team recommends that I have radiotherapy after my surgery.
  5. I have never had radiotherapy to my head or neck before.
  6. I am able to travel to Manchester or London for daily treatment over several weeks.
Answer every question to see your result.

What does participation involve?

If you take part, your treatment will be delivered at one of the two NHS proton beam therapy centres—either The Christie in Manchester or University College London Hospitals (UCLH). Treatment typically involves daily outpatient visits from Monday to Friday over several weeks. Free accommodation near the hospital is provided for patients who live far away, along with travel support.

During your visits, you will lie still on a treatment couch while the machine delivers targeted protons to your parotid area; each daily session takes about 30 to 45 minutes, with the beam itself on for only a few minutes. Alongside your treatment, you will have regular check-ups, hearing tests, and taste assessments. You will also be asked to complete simple questionnaires about your symptoms and quality of life. After your treatment ends, your care team will continue to monitor your recovery for several months and years through scheduled follow-up appointments.

Potential risks and benefits

The main hoped-for benefit is that you will experience fewer side effects—particularly less loss of taste and less severe dry mouth—than you would with standard radiotherapy. However, proton beam therapy is still a powerful radiation treatment and can cause side effects such as fatigue, skin redness or peeling around your cheek and neck, sore throat, and mouth ulcers. As with any clinical trial, taking part is completely voluntary. You are free to say no or withdraw at any point without it affecting your standard NHS care or your relationship with your medical team.

Locations (2)

  • University College London Hospitals NHS Foundation Trust
    Verified postcode
    London, United Kingdom· Recruiting
  • The Christie NHS Foundation Trust
    Verified postcode
    Manchester, United Kingdom· Recruiting

Common questions

Will I definitely receive proton beam therapy if I join?

Yes. This is not a randomised study, so there is no computer selection or dummy treatment. Every eligible patient who joins PRONTO will receive proton beam therapy.

Where does the treatment take place?

Treatment is given at one of two specialist NHS proton centres in the UK: The Christie NHS Foundation Trust in Manchester or University College London Hospitals (UCLH) in London.

What happens if I live far away from London or Manchester?

The NHS provides funded accommodation close to the treatment centres for patients who have to travel long distances, and support is available to help coordinate your travel.

Does taking part cost me anything?

No. Your treatment is funded by the NHS. You will not have to pay for your medical care or proton therapy sessions.

How does this study measure my taste?

Your doctors will use simple, patient-friendly questionnaires and occasional taste tests to track what flavours you can sense before, during, and after your radiotherapy.

How to find out more

Romelie Rieu

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Investigating the Role of Adjuvant Proton Beam Therapy in Pa…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.